Precede Biosciences
Bhishma Amlani currently serves as Senior Director of Scientific Strategy & Operations at Precede Biosciences, a position held since 2024. Prior to this role, Bhishma was Senior Director and Corporate Strategy Lead at Flagship Pioneering Stealth Co. from 2021 to 2023. Bhishma's earlier career includes positions as Project Leader and Consultant at the Boston Consulting Group from 2018 to October 2021, and as a Postdoctoral Fellow at NYU Langone Medical Center from 2013 to 2017. Bhishma began in research as a Graduate Researcher at Memorial Sloan Kettering Cancer Center from 2008 to 2012 and as a Visiting Undergraduate Researcher at Weill Cornell Medical College in 2006 and 2007. Bhishma holds a Ph.D. in Life Science from the University of Surrey, obtained between 2008 and 2012, and a Bachelor's Degree in Microbiology (Medical) from the University of Surrey, earned from 2004 to 2008.
This person is not in any teams
This person is not in any offices
Precede Biosciences
1 followers
We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test uncovers actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. By partnering with developers of new medicines and advancing our own diagnostic tests, we’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.